1672-2809
2015 Issue 6
Updates of New Molecular Entities Approved by FDA in 2014：Gastrointestinal, Neurological, Psoriasis, Rare Diseases and ImagingAgent
SUN Shu-sen;,MA Xiang;,HAN Rong;,ZHAO Zhi-gang;
SUN Shu-sen;,MA Xiang;,HAN Rong;,ZHAO Zhi-gang;
..............page:6-12,19
Introduction about the Final Rule of the Drug Information Label for Pregnant and Lactating Women Issued by FDA in 2014
Huo Ji-ping;,Qu Sheng-hui;,Zhao Zhi-gang;
Huo Ji-ping;,Qu Sheng-hui;,Zhao Zhi-gang;
..............page:13-19
Research on Drug Quality Classification among the Administration of Bidding
ZHOU Ming-yue;,SONG Min-xian;,YU Cheng-hang;
ZHOU Ming-yue;,SONG Min-xian;,YU Cheng-hang;
..............page:20-23,44
Cost-effectiveness Analysis of Dalitong Granule in Treatment of Functional Dyspepsia
FAN Chang-sheng;,HE Min-mei;
FAN Chang-sheng;,HE Min-mei;
..............page:24-34
Study on in vitro Dissolution of Vitamin C Yinqiao Tablets in Different Coating
AN Si-yang;,HU Fang;,JIANG Kun;,LI Xing;,YANG Lin-kui;,PAN Yu-jie;
AN Si-yang;,HU Fang;,JIANG Kun;,LI Xing;,YANG Lin-kui;,PAN Yu-jie;
..............page:35-39
Medication Analysis of Insulin in 20 Hospitals in Hangzhou from 2011 to 2013
WU Jia-ying;,RAO Yue-feng;,FENG Sheng-min;,ZHANG Xing-guo;
WU Jia-ying;,RAO Yue-feng;,FENG Sheng-min;,ZHANG Xing-guo;
..............page:40-44
..............page:45-47